ADMA Biologics, Inc.ADMANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
29.58
↑ 2264% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-1.37
Historical baseline
PeriodValueYoY Change
202529.58+46.3%
202420.22+156.4%
2023-35.85-207.7%
2022-11.65-324.1%
2021-2.75-23.9%
2020-2.22+50.7%
2019-4.50-174.1%
2018-1.64+2.2%
2017-1.68+47.3%
2016-3.19-